HLA – DR5 DRB1*1112 Test
Components: 4 mL (3 mL min.) whole blood in 1 Lavender Top (EDTA) tube OR 6 mL (3 mL min.) whole blood in 1 Yellow Top (ACD) tube. Ship refrigerated. DO NOT FREEZE.
Price: 1010.0 AED
Report Delivery: 10-12 days
Method: Reverse SSOP – Luminex
Test Type: Disease Association
Doctor: Physician
Test Department: Pre Test Information
No special preparation required.
Test Details
The HLA-DR5 (DRB1*11/12) test is a genetic test that identifies the presence of the HLA-DR5 gene variant in an individual’s DNA. HLA genes encode for proteins called human leukocyte antigens (HLAs), which play a crucial role in the immune system’s ability to recognize and respond to foreign substances, such as bacteria and viruses.
The HLA-DR5 variant is associated with an increased risk of developing certain autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus, and multiple sclerosis. This test is often used to assess an individual’s genetic susceptibility to these diseases and to aid in their diagnosis.
The test is typically performed using a blood sample or a cheek swab, and the DNA is analyzed to determine the presence or absence of the HLA-DR5 variant. The results can help healthcare professionals in assessing a person’s risk of developing autoimmune diseases and may guide treatment decisions or preventive measures.
It is important to note that having the HLA-DR5 variant does not necessarily mean a person will develop an autoimmune disease, as other genetic and environmental factors also contribute to disease development. Additionally, the absence of the HLA-DR5 variant does not rule out the possibility of developing autoimmune diseases.
The HLA-DR5 (DRB1*11/12) test is typically ordered by a healthcare provider, such as a rheumatologist or immunologist, and the results are interpreted in conjunction with other clinical and laboratory findings to make an accurate diagnosis and develop an appropriate treatment plan.
| Test Name | HLA – DR5 DRB1*1112 Test |
|---|---|
| Components | |
| Price | 1010.0 AED |
| Sample Condition | 4 mL (3 mL min.) whole blood in 1 Lavender Top (EDTA) tube OR6 mL (3 mL min.) whole blood in 1 Yellow Top (ACD) tube. Ship refrigerated. DO NOT FREEZE. |
| Report Delivery | 10-12 days |
| Method | Reverse SSOP – Luminex |
| Test type | Disease Association |
| Doctor | Physician |
| Test Department: | |
| Pre Test Information | No special preparation required |
| Test Details | The HLA-DR5 (DRB1*11/12) test is a genetic test that identifies the presence of the HLA-DR5 gene variant in an individual’s DNA. HLA genes encode for proteins called human leukocyte antigens (HLAs), which play a crucial role in the immune system’s ability to recognize and respond to foreign substances, such as bacteria and viruses. The HLA-DR5 variant is associated with an increased risk of developing certain autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus, and multiple sclerosis. This test is often used to assess an individual’s genetic susceptibility to these diseases and to aid in their diagnosis. The test is typically performed using a blood sample or a cheek swab, and the DNA is analyzed to determine the presence or absence of the HLA-DR5 variant. The results can help healthcare professionals in assessing a person’s risk of developing autoimmune diseases and may guide treatment decisions or preventive measures. It is important to note that having the HLA-DR5 variant does not necessarily mean a person will develop an autoimmune disease, as other genetic and environmental factors also contribute to disease development. Additionally, the absence of the HLA-DR5 variant does not rule out the possibility of developing autoimmune diseases. The HLA-DR5 (DRB1*11/12) test is typically ordered by a healthcare provider, such as a rheumatologist or immunologist, and the results are interpreted in conjunction with other clinical and laboratory findings to make an accurate diagnosis and develop an appropriate treatment plan. |
